Benoît Fouchaq, CEO of Biofortis SASAs part of a new strategy, Mérieux NutriSciences has decided to sell the majority...
Blog
[EVENT] Biofortis is sponsor of IHMC 2021
International HumanMicrobiome Consortium Congress (IHMC)June, 27th to 29th 2021Biofortis is proud to announce that we...
[INFOGRAPHICS] What happened in Biofortis, since January 2021 ?
For more information, don't hesitate to contact us :
Personalized Nutrition – Interview Nina Vinot (Probiotical)
Last month, Alessandra De Martino & Stéphane Deniau (Biofortis Mérieux NutriSciences) attended to the IPA (International Probiotics Association) World Congress & Probiota 2018 event in...
Exploring the Microbiome (bio)diversity
Microbes, microbiota, or microbiome Microbes are microorganisms, i.e. organisms which are microscopic (invisible to the naked eye). They can be both multi and unicellular. A microbe could be a...
New medical device Regulation 2017/745: Impact in nutrition field?
The new regulation 2017/745 on medical devices was adopted on spring 2017, replacing the existing directives. A transitional period is ongoing to May 2020, date of the implementation. According to...
Preclinical Microbiome Research
FROM RESEARCH TO MICROBIOME INSIGHTS These last years, murine genetics manipulations have lead to development of multiple murine models (germ-free, gnotobiotic…). Consequently, microbiome...
Microbiome involvement in satiety regulation
In satiety regulation, the balance between anorexigenic (PP, CCK, PYY3-36, incretins, leptin, OXM) and orexigenic (ghrelin, insl5, adiponectin) signals is determinant. A special attention should be...
Targeting Microbiota with Hervé Blottière
Biofortis’ scientist experts were attending the 5th World Congress on Targeting Microbiota organised by the International Society of Microbiota. During this two-day conference in Berlin, a lot of...


